Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.7 USD | +0.23% | +2.08% | +18.06% |
06-04 | Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM | |
06-03 | Merck: promising results in melanoma treatment | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.06% | 326B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+4.63% | 286B | |
+17.92% | 246B | |
+11.02% | 213B | |
-2.90% | 213B | |
+2.43% | 167B | |
+6.67% | 165B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Morgan Stanley Raises Merck & Company's Price Target to $92 From $88, Maintains Equalweight Rating